IP Library Granted Patent US 12,419,804
Granted Patent B2
US 12,419,804 · App. 16/862,451 · Granted Sep 23, 2025

Systems and methods of managing and evaluating emergency medical procedures

Inventor: Robert G. Walker (Seattle, WA)
Assignee: Physio-Control, Inc.
A61H31/005A61B5/0816A61B5/0836A61B5/6801A61N1/39044A61H2201/10A61H2230/405A61H2230/425
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,419,804
App. No.
16/862,451
Granted
Sep 23, 2025
Kind
B2
Abstract

Systems, apparatuses, and methods directed to the collection and analysis of data related to a patient during an emergency advanced airway management process. The collected data may be obtained using various types of sensors, with the data collection process being managed or coordinated by a suitable system, such as a combination monitor-defibrillator. The monitor-defibrillator (alone or in combination with other system elements, such as a wired or wireless communications capability, a processor, data storage, etc.) may include a capability to process some or all of the acquired data, and in response indicate to a user when some of the collected data may be unreliable.

Claims (58)

1. A device for evaluating measured carbon dioxide (CO 2 ) content in an exhaled breath, comprising:

an input configured to receive the measured CO 2 content;

a user interface; and

a processor configured to:

generate a measurement based on the measured CO 2 content;

identify alternating positive and negative slopes in the measured CO 2 content;

determine that the measured CO 2 content comprises positive pressure ventilation induced artifacts by:

determining that the alternating positive and negative slopes have greater than a threshold steepness; and

determining that a periodicity of the positive and negative slopes is above a threshold periodicity;

in response to determining that the measured CO 2 content comprises the positive pressure ventilation induced artifacts,

determine a likelihood that the measurement is unreliable;

display, on the user interface, a portion of the measurement indicative of artifacts in a first color and a portion of the measurement devoid of artifacts in a second color; and

indicate, on the user interface, the likelihood that the measurement is unreliable.

2. The device of claim 1 , wherein the processor is further configured to determine a characteristic of the positive pressure ventilation induced artifacts and the user interface is configured to indicate the characteristic.

3. The device of claim 1 , wherein the measurement comprises an end tidal CO 2 value or a respiratory rate.

4. A device for evaluating measured carbon dioxide (CO 2 ) content in an exhaled breath, comprising:

an input configured to receive the measured CO 2 content;

a user interface; and

a processor configured to:

generate a measurement based on the measured CO 2 content;

identify alternating positive and negative slopes in the measured CO 2 content;

determine that the measured CO 2 content comprises positive pressure ventilation induced artifacts by:

determining that the alternating positive and negative slopes have greater than a threshold steepness; and

determining that a periodicity of the positive and negative slopes is above a threshold periodicity;

in response to determining that the measured CO 2 content comprises positive pressure ventilation induced artifacts, determine a likelihood that the measurement is unreliable;

highlight, on the user interface, a portion of the measurement indicative of the positive pressure ventilation induced artifacts; and

indicate, on the user interface, the likelihood the measurement is unreliable.

5. The device of claim 4 , wherein the processor is further configured to determine a characteristic of the positive pressure ventilation induced artifacts and the user interface is configured to indicate the characteristic.

6. The device of claim 5 , wherein the characteristic comprises a timing of the positive pressure ventilation induced artifacts.

7. The device of claim 5 , wherein the characteristic comprises a proportion of a total interval in which the positive pressure ventilation induced artifacts are present.

8. The device of claim 7 , wherein the processor is configured to determine that the measured CO 2 content comprises the positive pressure ventilation induced artifacts by determining that a magnitude of the positive pressure ventilation induced artifacts in the total interval is equal to or greater than a threshold.

9. The device of claim 8 , wherein the device is a monitor-defibrillator or a post-event review device.

10. A method for evaluating measured carbon dioxide (CO 2 ) content in an exhaled breath, the method comprising:

receiving the measured CO 2 content;

identify alternating positive and negative slopes in the measured CO 2 content;

determining, by a processor, that the measured CO 2 content comprises artifacts by:

determining that the alternating positive and negative slopes have greater than a threshold steepness; and

determining that a periodicity of the positive and negative slopes is above a threshold periodicity, the artifacts comprising ventilation induced artifacts;

in response to determining that the measured CO 2 content comprises the artifacts, determining, by the processor, a likelihood that the measured CO2 content is unreliable;

displaying, by a user interface, a portion of the measured CO 2 content indicative of the artifacts in a first color and a portion of the measured CO 2 content devoid of artifacts in a second color; and

indicating, by the user interface, the likelihood that the measured CO 2 content is unreliable.

11. The method of claim 10 , further comprising:

generating a measurement based on the measured CO 2 content; and

indicating a likelihood that the measurement is unreliable when the measured CO 2 content includes the artifacts.

12. The method of claim 11 , wherein the measurement comprises an end tidal CO 2 value or a respiratory rate.

13. The method of claim 11 , further comprising concurrently displaying, on a display, the measurement and the likelihood the measurement is unreliable.

14. The device of claim 1 , wherein the processor is configured to:

determine the likelihood that the measurement is unreliable by comparing a magnitude of the artifacts to a threshold.

15. The device of claim 14 , wherein the processor is further configured to:

determine that the artifacts comprise chest compression induced artifacts; and

in response to determining that the artifacts comprise chest compression induced artifacts, determine a magnitude of the chest compression induced artifacts; and

wherein the user interface is further configured to indicate the magnitude of the chest compression induced artifacts.

16. The device of claim 1 , further comprising a CO 2 sensor configured to measure the CO 2 content.

17. The method of claim 12 , further comprising:

determining a magnitude of the artifacts; and

displaying, by the user interface, the magnitude of the artifacts.

18. The device of claim 1 , wherein the processor is further configured to:

disable an end-tidal CO 2 alarm in response to determining the likelihood that the measurement is unreliable.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2020
From: WALKER, ROBERT
To: PHYSIO-CONTROL, INC.
Reel/Frame 052560/0324 →
Continuity (3)
Continuation In Part 16478817
Provisional Application 62448934 · Jan 20, 2017
Related Publication 20200253820A1 · Aug 13, 2020
References Cited (28)
US 4387722A · Kearns · 1983 [cited by examiner]
US 9585617B2 · Babaeizadeh · 2017 [cited by examiner]
US 11147507B2 · Ronen et al. · 2021 [cited by applicant]
US 20040122476A1 · Wung · 2004 [cited by applicant]
US 20080215102A1 · Myklebust · 2008 [cited by examiner]
US 20100174161A1 · Lynn · 2010 [cited by examiner]
US 20110040713A1 · Colman · 2011 [cited by examiner]
US 20120137249A1 · Milne et al. · 2012 [cited by applicant]
US 20130289364A1 · Colman · 2013 [cited by examiner]
US 20130324873A1 · Babaeizadeh · 2013 [cited by examiner]
US 20140330155A1 · Koninklijke · 2014 [cited by applicant]
US 20150182712A1 · Kelly et al. · 2015 [cited by applicant]
US 20150265217A1 · Penders · 2015 [cited by examiner]
US 20160058286A1 · Joshua et al. · 2016 [cited by applicant]
US 20160287170A1 · Ronen · 2016 [cited by examiner]
US 20180182475A1 · Cossler et al. · 2018 [cited by applicant]
US 20190216390A1 · Tang et al. · 2019 [cited by applicant]
US 20200170513A1 · Walker · 2020 [cited by applicant]
US 20210251501A1 · Moon · 2021 [cited by examiner]
US 20230364366A1 · Walker · 2023 [cited by applicant]
EP 2217141A2 · 2010 [cited by examiner]
JP 5395960B2 · 2014 [cited by examiner]
WO WO2012080920A1 · 2012 [cited by examiner]
International Preliminary Report on Patentability dated Jul. 23, 2019, International App. No. PCT/US2018/014565, Filed Jan. 19, 2018. [cited by applicant]
International Search Report and Written Opinion dated Apr. 4, 2018, International App. No. PCT/US2018/014565, Filed Jan. 19, 2018. [cited by applicant]
Office Action for U.S. Appl. No. 16/478,817, dated Feb. 22, 2021, Walker, “Systems and Methods of Managing and Evaluating Airway Procedures”, 22 pages. [cited by applicant]
Office Action for U.S. Appl. No. 16/478,817, dated Aug. 17, 2021, Walker, “Systems and Methods of Managing and Evaluating Airway Procedures”, 18 Pages. [cited by applicant]
Office Action for U.S. Appl. No. 16/478,817, mailed on Mar. 27, 2023, Walker, “Systems and Methods of Managing and Evaluating Airway Procedures ”, 12 pages. [cited by applicant]